Notice for transfer of equity shares of the Company to the Investor Education and Protection Fund ("IEPF")
Indoco's formulation plant at Baddi (Plant III) receives EU GMP Certification
Enclosed the Annual Secretarial Compliance Report dated 13-05-2026 for the Financial Year 2025-2026 issued by our Secretarial auditor CS Ajit Sathe, Proprietor of M/s. A.Y.Sathe & Co, Company Secretaries.
Intimation regarding completion of transfer of Ophthalmic Division of the Company to Sunways (India) Private Limited
The Company hereby regrets to inform about the sad demise of Dr. Anand Nadkarni (DIN : 06881461) Non Executive Director of the Company today i.e. Friday, 15th May, 2026.
Press Release:- Indoco Remedies successfully clears Malta Medicines Authority Audit
Transcript of Earnings Conference Call on Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31-03-2026
Publication of Audited Standalone & Consolidated Financial Results for the Quarter and Year ended 31-03-2026
Audio recording of Earnings Conference Call on Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March, 2026
Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March, 2026
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 426.50 | 481.73 | 459.42 | 449.64 | 431.49 | 432.66 | 410.55 | 390.21 | 437.89 | 484.67 | 445.36 | 475.61 |
| YOY Revenue Growth % | 4.48% | 11.24% | 15.09% | 5.02% | 1.17% | -10.19% | -10.64% | -13.22% | 1.48% | 12.02% | 8.48% | 21.89% |
| Other Income | 0.41 | 4.43 | 2.35 | 2.66 | 1.03 | 1.56 | 0.85 | 2.02 | 1.63 | 0.76 | 0.98 | -0.04 |
| Total Income | 426.91 | 486.16 | 461.77 | 452.30 | 432.52 | 434.22 | 411.40 | 392.23 | 439.52 | 485.43 | 446.34 | 475.57 |
| Total Expenses + | 393.00 | 439.88 | 430.94 | 439.05 | 425.55 | 439.06 | 443.35 | 437.75 | 476.18 | 498.43 | 471.50 | 504.31 |
| Cost of Materials Consumed | 102.97 | 130.94 | 129.30 | 121.80 | 106.24 | 94.26 | 109.91 | 85.86 | 105.53 | 112.99 | 97.89 | 109.18 |
| Employee Benefit Expense | 91.54 | 92.12 | 89.97 | 88.30 | 97.26 | 92.88 | 97.55 | 106.36 | 107.02 | 103.23 | 106.03 | 109.41 |
| Other Expenses | 145.11 | 170.93 | 164.23 | 171.59 | 144.97 | 162.73 | 187.05 | 178.66 | 178.37 | 193.05 | 187.40 | 175.48 |
| Operating Profit | 33.50 | 41.85 | 28.48 | 10.59 | 5.94 | -6.40 | -32.80 | -47.54 | -38.29 | -13.76 | -26.14 | -28.70 |
| OPM % | 7.9% | 8.7% | 6.2% | 2.4% | 1.4% | -1.5% | -8% | -12.2% | -8.7% | -2.8% | -5.9% | -6% |
| Profit Before Tax + | 33.91 | 46.28 | 22.63 | 32.98 | 6.97 | -4.84 | -30.96 | -45.52 | -36.66 | -13.53 | -31.31 | -25.00 |
| Tax Expense | 9.73 | 11.04 | 7.07 | 10.95 | 5.15 | 5.17 | -2.56 | -4.18 | -0.31 | -4.32 | -1.86 | -1.32 |
| Tax % | 28.7% | 23.9% | 31.2% | 33.2% | 73.9% | - | - | - | - | - | - | - |
| Profit After Tax | 24.18 | 35.24 | 15.56 | 22.03 | 1.82 | -10.01 | -28.40 | -41.34 | -36.35 | -9.21 | -29.45 | -23.68 |
| EPS (Basic) | 2.62 | 3.82 | 1.69 | 2.39 | 0.20 | -1.09 | -3.08 | -4.48 | -3.94 | -1.00 | -3.20 | -2.57 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 1,845.32 | 1,664.92 | 1,817.29 | 1,668.61 | 1,540.75 | 1,241.53 | 1,106.59 |
| YOY Revenue Growth % | 10.84% | -8.38% | 8.91% | 8.3% | 24.1% | 12.19% | - |
| Other Income | 3.33 | 5.45 | 9.85 | 2.34 | 2.33 | 3.12 | 2.44 |
| Total Income | 1,848.65 | 1,670.37 | 1,827.14 | 1,670.95 | 1,543.08 | 1,244.65 | 1,109.03 |
| Total Expenses + | 1,952.22 | 1,745.73 | 1,702.87 | 1,478.15 | 1,306.51 | 1,112.65 | 915.63 |
| Cost of Materials Consumed | 425.60 | 396.27 | 485.01 | 412.02 | 393.66 | 303.20 | 262.68 |
| Employee Benefit Expense | 425.69 | 394.05 | 361.93 | 322.58 | 293.70 | 274.02 | 256.51 |
| Other Expenses | 736.09 | 673.43 | 651.86 | 538.64 | 462.92 | 389.13 | 396.44 |
| Operating Profit | -106.90 | -80.81 | 114.42 | 190.46 | 234.24 | 128.88 | 190.96 |
| OPM % | -5.8% | -4.9% | 6.3% | 11.4% | 15.2% | 10.4% | 17.3% |
| Profit Before Exceptional | -103.57 | -75.36 | 124.27 | 192.80 | 236.57 | 132.00 | 28.58 |
| Exceptional Items | -2.94 | 0.99 | 11.53 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax + | -106.51 | -74.37 | 135.80 | 192.80 | 236.57 | 132.00 | 28.58 |
| Tax Expense | -7.81 | 3.58 | 38.79 | 50.55 | 81.77 | 38.95 | 4.46 |
| Tax % | - | - | 28.6% | 26.2% | 34.6% | 29.5% | 15.6% |
| Profit After Tax | -98.70 | -77.95 | 97.01 | 142.25 | 154.80 | 93.05 | 24.12 |
| EPS (Basic) | -10.70 | 8.46 | 10.53 | 15.44 | 16.80 | 10.10 | 2.62 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Non-Current Assets + | 1,399.92 | 1,428.57 | 1,190.06 | 850.02 | 712.47 | 692.53 | 0.00 |
| Property, Plant & Equipment | 969.83 | 849.06 | 788.22 | 612.20 | 531.84 | 528.41 | 0.00 |
| Capital Work in Progress | 28.29 | 276.12 | 102.87 | 55.39 | 52.82 | 25.12 | 0.00 |
| Non-Current Investments | 1.46 | 1.46 | 1.46 | 1.46 | 0.02 | 0.02 | 0.00 |
| Goodwill | 21.52 | 21.52 | 21.52 | 0.09 | 0.09 | 0.09 | 0.00 |
| Other Intangible Assets | 201.76 | 126.30 | 144.55 | 65.97 | 23.16 | 41.53 | 0.00 |
| Current Assets + | 1,193.35 | 1,001.34 | 954.67 | 808.18 | 773.62 | 622.53 | 0.00 |
| Inventories | 405.21 | 419.35 | 353.06 | 325.99 | 310.52 | 237.85 | 0.00 |
| Trade Receivables | 489.17 | 352.41 | 406.20 | 350.94 | 297.24 | 233.82 | 0.00 |
| Cash and Cash Equivalents | 25.93 | 12.10 | 14.86 | 10.93 | 17.47 | 9.42 | 0.00 |
| Current Investments | 0.00 | 0.00 | 7.24 | 1.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | |||||||
| Total Equity | 932.11 | 1,018.38 | 1,110.50 | 1,028.25 | 904.64 | 768.99 | 0.00 |
| Equity Share Capital | 18.46 | 18.45 | 18.44 | 18.43 | 18.43 | 18.43 | 0.00 |
| Other Equity | 920.82 | 1,003.55 | 1,091.46 | 1,009.82 | 886.21 | 750.56 | 0.00 |
| Non-Current Liabilities | 608.61 | 603.54 | 421.90 | 205.44 | 156.59 | 139.15 | 0.00 |
| Current Liabilities | 1,052.55 | 807.99 | 612.33 | 424.51 | 424.86 | 406.92 | 0.00 |
| Total Liabilities | 1,661.16 | 1,411.53 | 1,034.23 | 629.95 | 581.45 | 546.07 | 0.00 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activities | 192.23 | 94.93 | 156.70 | 178.83 | 173.83 | 82.22 | 0.00 |
| Cash from Investing Activities | -101.61 | -339.11 | -433.83 | -208.18 | -121.41 | -66.69 | 0.00 |
| Cash from Financing Activities | -76.80 | 241.42 | 280.44 | 22.81 | -44.37 | -29.87 | 0.00 |
| Net Increase/Decrease in Cash | 13.82 | -2.76 | 3.31 | -6.54 | 8.05 | -14.34 | 0.00 |